drugset / Trial / NCT02470117

Alginate-based Reflux Suppressant and Magnesium-aluminium Antacid Gel for Treatment of Heartburn in Pregnancy

NCT02470117 ↗

Phase 4 Completed 100 enrolled Chulalongkorn University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates the efficacy of alginate-based reflux suppressant and magnesium-aluminium antacid gel for treatment of heartburn in pregnancy. Half of the participants will receive alginate-based reflux suppressant, while the other half will receive magnesium-aluminium antacid gel.

Timeline

Start
2015-06
Primary completion
2016-07
Completion
2016-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alginate-based reflux suppressant Other / unclassified 15 ml Oral
Comparator magnesium-aluminium antacid gel Unknown 15 ml Oral

Indications

No indication recorded.